Clinical trials: Cutaneous Common Warts
Cutaneous Warts
Intralesional Bleomycin Versus Cryotherapy for Treatment of Cutaneous Warts
The purpose of the study was to determine the efficacy of intralesional bleomycin in comparison to cryotherapy on participants having cutaneous warts.
- Trial name
- NCT05023408
- Testing
- Bleomycin Injection, Cryotherapy
- Where
- Pakistan
- Volunteers
- 154 people, healthy volunteers welcome
- Sponsor
- Jinnah Postgraduate Medical Centre
Cutaneous Warts
First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts
This phase I/IIa study has an open-label, First-in-Human (FIH), single center design to assess the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of multiple doses of topically applied CLS003 in healthy subjects with…
- Trial name
- NCT02106260
- Testing
- CLS003
- Where
- Netherlands
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Maruho Co., Ltd.
Warts
the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.
To compare between the efficacy and safety of topical ivermectin alone, microneedling with topical ivermectin and topical salicylic acid in treatment of cutaneous warts.
- Trial name
- NCT07396714
- Testing
- Ivermectin, microneedling, Salicylic Acid
- Volunteers
- 88 people
- Sponsor
- Assiut University
Cutaneous Warts
Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts
A total of 60 female patients (30 patients in each group) with cutaneious warts diagnosed by a consultant dermatologist on physical examination were included in this study.
- Trial name
- NCT05739786
- Testing
- liq nitrogen, intralesional vitamin D3
- Where
- Pakistan
- Volunteers
- 60 people
- Sponsor
- Combined Military Hospital Abbottabad
Cutaneous Warts
Role of Intralesional Combined Injection of Furosemide and Digoxin in Cutaneous Warts at Tertiary Care Hospital in Karachi.
Identify the effects of combined intralesional furosemide 20mg/2ml and digoxin 0.5mg/2ml in cutaneous warts given weekly are rather safe and effective treatment for cutaneous warts, focusing on their effectiveness and safety, at…
- Trial name
- NCT06821594
- Testing
- Furosemide
- Where
- Pakistan
- Volunteers
- 40 people
- Sponsor
- Jinnah Postgraduate Medical Centre
Warts
Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts
This double-blinded clinical trial randomly assigns participants with refractory cutaneous warts to receive either treatment with the human papillomavirus (HPV) vaccine or a placebo to assess the efficacy of HPV vaccination for…
- Trial name
- NCT05625633
- Testing
- Human Papillomavirus 9-valent Vaccine, Recombinant, Normal Saline
- Where
- 2 sites in United States
- Volunteers
- 120 people
- Sponsor
- Western Institute for Veterans Research
Recalcitrant Cutaneous Warts
Oral Zinc Gluconate as Treatment for Recalcitrant Cutaneous Warts: A Randomized, Double-blind, Placebo-controlled Trial
Up to one-third of common warts can remain recalcitrant, an occurrence that has been attributed to impaired cell-mediated immunity. At present, no guidelines exist for the management of recalcitrant cutaneous warts.
- Trial name
- NCT01783353
- Testing
- Zinc gluconate, Corn starch pill
- Where
- Philippines
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- Philippine Dermatological Society
Cutaneous Common Warts
A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts
To evaluate the efficacy and safety of six (6) weeks of once daily application of Furosemide Topical Gel 0.125% (CLS006) compared to vehicle in subjects ≥ 2 years of age with nongenital cutaneous common warts (verruca vulgaris).
- Trial name
- NCT03259620
- Testing
- CLS006, CLS006 Vehicle
- Where
- 35 sites in United States
- Volunteers
- 491 people
- Sponsor
- Maruho Co., Ltd.
Vulvar Intraepithelial Neoplasia, Genital Warts
SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma
This pilot clinical study is to evaluate the efficacy \& safety of SR-T100 gel (2.3% of SM in Solanum undatum plant extract) in patients with VIN(s) or EGW(s).
- Trial name
- NCT01676792
- Testing
- SR-T100 gel with 2.3% of SM in Solanum undatum plant extract
- Where
- Taiwan
- Volunteers
- 29 people
- Sponsor
- National Cheng-Kung University Hospital
Warts
Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts
Warts are common and infectious viral diseases of the skin and are prevalent worldwide. Warts are caused by the human papilloma virus (HPV), which has more than 100 strains; some of them are known to be premalignant .Although…
- Trial name
- NCT03158168
- Testing
- Candida Antigen, Zinc Sulfate
- Where
- Egypt
- Volunteers
- 70 people
- Sponsor
- Assiut University
Human Papillomavirus Infection
Serum Galectin-3 as a Marker of Human Papillomavirus Infection
This study aimed to assess the serum Galectin-3 levels in patients with warts both before and after cryotherapy and to investigate its potential contribution to the pathogenesis of human papillomavirus infection.
- Trial name
- NCT06005389
- Testing
- cryotherapy, serum Galectin-3 assay
- Where
- Egypt
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Assiut University
Warts
Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts
Warts are common epidermal growths caused by various strains of human papilloma virus (HPV). Viral warts are common with a prevalence rate of 7-12%.
- Trial name
- NCT05781841
- Testing
- Detection of expression of SOCS3 gene, Detection of expression of IFN-α gene, Detection of expression of IFN-β gene
- Where
- Egypt
- Volunteers
- 100 people
- Sponsor
- Sohag University
Verruca Vulgaris
A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin
The purpose of the study was to see if liquid nitrogen, a commonly used treatment for warts, is more effective if it is used alone, or if it is more effective if combined with cantharidin, a topical treatment also commonly used…
- Trial name
- NCT01084824
- Testing
- Liquid nitrogen and cantharidin
- Where
- United States
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- North Idaho Dermatology
Viral Wart, Plantar Wart
Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir
The goal of this clinical trial is to learn if injecting acyclovir (an antiviral drug) or vitamin D3 directly into skin warts works to clear them in people aged 12 and older with common, plantar, flat, or periungual (around the…
- Conditions
- Viral Wart, Plantar Wart, Common Warts (Verruca Vulgaris), Common Wart
- Trial name
- NCT07448844
- Testing
- Intralesional Acyclovir, Intralesional Vitamin D3
- Where
- 2 sites in Pakistan
- Volunteers
- 40 people
- Sponsor
- Riphah International University
Warts, Warts Hand
CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts
This prospective, multicenter, single-blinded, randomized comparison study is designed to compare the safety and effectiveness of the CellFX System to Cryosurgery for the clearance of cutaneous non-genital common warts on all…
- Conditions
- Warts, Warts Hand, Verruca
- Trial name
- NCT04738734
- Testing
- CellFX System Device, Cryosurgery Liquid Nitrogen Sprayer
- Where
- 10 sites in United States
- Volunteers
- 150 people
- Sponsor
- Pulse Biosciences, Inc.
Cutaneous Common Warts
A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts
To evaluate the efficacy and safety of six (6) weeks of once daily application of Furosemide Topical Gel 0.125% (CLS006) compared to vehicle in subjects ≥ 2 years of age with nongenital cutaneous common warts (verruca vulgaris).
- Trial name
- NCT02971891
- Testing
- CLS006 (Furosemide) Topical Gel, Vehicle Topical Gel
- Where
- 30 sites in United States
- Volunteers
- 484 people
- Sponsor
- Maruho Co., Ltd.
Warts
Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts
Hyperthermia treatment (hyperthermia) refers to treating diseases with temperature (39-45 ° C) beyond normal body temperature,. It has been reported that local warming at 44 ° C is able to effectively mobilize the body's immunity…
- Trial name
- NCT06812065
- Testing
- Hydrogen Peroxide 3 % Topical Solution, Local Hyperthermia at 44℃
- Where
- 2 sites in China
- Volunteers
- 300 people
- Sponsor
- First Hospital of China Medical University
Cutaneous Warts
A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.
A phase 2, randomized, vehicle-controlled, double-blind study to assess the efficacy, safety and pharmacodynamics (PD) of topically applied CLS003 in otherwise healthy patients with cutaneous warts.
- Trial name
- NCT02333643
- Testing
- CLS003, Furosemide, Digoxin
- Where
- Netherlands
- Volunteers
- 81 people
- Sponsor
- Maruho Co., Ltd.
Cutaneous Warts, Human Papilloma Virus
Infrared Bioeffect System for the Treatment of Cutaneous Warts
Local hyperthermia at 44℃ can promote some alterations of immulogical indicators. The procedure is convenient in clinic, has high tolerance with less trauma and less pain.
- Trial name
- wart (NCT03734003)
- Testing
- liquid nitrogen, controllable infrared bioeffect system
- Where
- China
- Volunteers
- 88 people
- Sponsor
- First Hospital of China Medical University
Cutaneous Warts, Human Papilloma Virus (HPV)
Furosemide-Digoxin vs. Polidocanol for Cutaneous Warts
This study compares the effectiveness and safety of two different intralesional treatments for cutaneous warts: a combination of furosemide and digoxin versus polidocanol.
- Trial name
- NCT07307131
- Testing
- Intralesional combined furosemide (10 mg/ml) and digoxin (0.25 mg/ml), Intralesional polidocanol 2%
- Where
- Egypt
- Volunteers
- 64 people
- Sponsor
- Benha University